SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3ol2'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1WG8_A_SAMA3142_0
(PREDICTED
S-ADENOSYLMETHIONINE
-DEPENDENT
METHYLTRANSFERASE)		 3ol2 SEMAPHORIN-4D
PLEXIN-B1
(Homo
sapiens;
Homo
sapiens) 		5 / 12 GLY B 178
GLY B 179
GLY B 180
ASP B  78
PHE A 393
 None
 1.15A 1wg8A-3ol2B:
undetectable		 1wg8A-3ol2B:
22.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1WG8_B_SAMB3141_0
(PREDICTED
S-ADENOSYLMETHIONINE
-DEPENDENT
METHYLTRANSFERASE)		 3ol2 SEMAPHORIN-4D
PLEXIN-B1
(Homo
sapiens;
Homo
sapiens) 		5 / 12 GLY B 178
GLY B 179
GLY B 180
ASP B  78
PHE A 393
 None
 1.12A 1wg8B-3ol2B:
undetectable		 1wg8B-3ol2B:
22.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2COJ_B_GBNB420_1
(BRANCHED CHAIN
AMINOTRANSFERASE 1,
CYTOSOLIC)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		5 / 9 VAL A 513
TYR A 436
GLY A 433
THR A 434
ALA A 430
 None
 1.40A 2cojA-3ol2A:
undetectable
2cojB-3ol2A:
undetectable		 2cojA-3ol2A:
21.26
2cojB-3ol2A:
21.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2NNK_A_ROCA401_2
(PROTEASE)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		3 / 3 ARG A 412
VAL A 404
THR A 332
 None
 0.85A 2nnkA-3ol2A:
undetectable		 2nnkA-3ol2A:
8.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VCV_K_ASDK1224_1
(GLUTATHIONE
S-TRANSFERASE A3)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		4 / 6 LEU A 288
PRO A 411
ALA A 324
ALA A  25
 None
 0.99A 2vcvK-3ol2A:
undetectable		 2vcvK-3ol2A:
16.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WEK_A_DIFA1375_1
(ZINC-BINDING ALCOHOL
DEHYDROGENASE
DOMAIN-CONTAINING
PROTEIN 2)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		3 / 3 LEU A 118
TYR A 124
GLN A 116
 None
NAG  A9000 ( 3.6A)
None
 0.62A 2wekA-3ol2A:
undetectable		 2wekA-3ol2A:
19.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X8O_A_OINA1314_1
(CHOLINE-BINDING
PROTEIN F)		 3ol2 PLEXIN-B1
(Homo
sapiens) 		4 / 5 ASP B 359
ARG B 210
TYR B 214
GLU B 213
 None
 1.09A 2x8oA-3ol2B:
undetectable		 2x8oA-3ol2B:
17.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BRF_A_SORA2_0
(LIN-12 AND GLP-1
PHENOTYPE PROTEIN 1,
ISOFORM A)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		3 / 3 LYS A  94
LYS A  88
VAL A  89
 None
 0.83A 3brfA-3ol2A:
undetectable		 3brfA-3ol2A:
22.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K4V_B_ROCB201_2
(HIV-1 PROTEASE)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		3 / 3 ARG A 412
VAL A 404
THR A 332
 None
 0.79A 3k4vA-3ol2A:
undetectable		 3k4vA-3ol2A:
8.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LCV_B_SAMB301_0
(SISOMICIN-GENTAMICIN
RESISTANCE METHYLASE
SGM)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		5 / 12 TYR A 310
THR A 428
ILE A 423
ASP A 295
LEU A 476
 None
 1.37A 3lcvB-3ol2A:
undetectable		 3lcvB-3ol2A:
19.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LCV_B_SAMB301_1
(SISOMICIN-GENTAMICIN
RESISTANCE METHYLASE
SGM)		 3ol2 SEMAPHORIN-4D
PLEXIN-B1
(Homo
sapiens;
Homo
sapiens) 		3 / 3 ARG B 170
ASP B  78
GLN A 344
 None
 0.90A 3lcvB-3ol2B:
undetectable		 3lcvB-3ol2B:
21.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LOQ_A_ACTA278_0
(UNIVERSAL STRESS
PROTEIN)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		3 / 3 SER A 383
GLY A 262
SER A 273
 None
 0.65A 3loqA-3ol2A:
undetectable		 3loqA-3ol2A:
18.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NDU_D_ROCD100_3
(PROTEASE)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		3 / 3 ARG A 412
VAL A 404
THR A 332
 None
 0.85A 3nduD-3ol2A:
undetectable		 3nduD-3ol2A:
8.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PWR_A_ROCA401_2
(PROTEASE)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		3 / 3 ARG A 412
VAL A 404
THR A 332
 None
 0.82A 3pwrA-3ol2A:
undetectable		 3pwrA-3ol2A:
8.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3R24_A_SAMA302_1
(2'-O-METHYL
TRANSFERASE)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		3 / 3 TYR A 519
ASP A 437
ASP A 426
 None
 0.80A 3r24A-3ol2A:
undetectable		 3r24A-3ol2A:
18.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RGL_A_GLYA301_0
(GLYCYL-TRNA
SYNTHETASE ALPHA
SUBUNIT)		 3ol2 PLEXIN-B1
(Homo
sapiens) 		4 / 8 GLY B 125
GLN B  57
GLU B  65
THR B  46
 None
 0.91A 3rglA-3ol2B:
undetectable		 3rglA-3ol2B:
19.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TL9_A_ROCA401_2
(PROTEASE)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		3 / 3 ARG A 412
VAL A 404
THR A 332
 None
 0.84A 3tl9A-3ol2A:
undetectable		 3tl9A-3ol2A:
9.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F84_A_SAMA501_0
(GERANYL DIPHOSPHATE
2-C-METHYLTRANSFERAS
E)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		5 / 12 GLY A 490
GLY A 494
VAL A 473
LEU A 466
VAL A 487
 None
 1.23A 4f84A-3ol2A:
undetectable		 4f84A-3ol2A:
20.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FE1_A_PQNA846_1
(PHOTOSYSTEM I P700
CHLOROPHYLL A
APOPROTEIN A1
PHOTOSYSTEM I
REACTION CENTER
SUBUNIT IX)		 3ol2 PLEXIN-B1
(Homo
sapiens) 		5 / 10 ARG B 254
ALA B 226
LEU B 253
GLY B 159
ALA B 279
 None
 1.22A 4fe1A-3ol2B:
undetectable
4fe1J-3ol2B:
undetectable		 4fe1A-3ol2B:
22.12
4fe1J-3ol2B:
4.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FFW_A_715A801_2
(DIPEPTIDYL PEPTIDASE
4)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		3 / 3 PHE A  71
TYR A  48
TYR A  50
 None
NAG  A1000 ( 4.6A)
None
 1.04A 4ffwA-3ol2A:
2.8		 4ffwA-3ol2A:
20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ODO_A_FK5A205_2
(PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
SLYD)		 3ol2 PLEXIN-B1
(Homo
sapiens) 		4 / 4 THR B  70
ARG B 122
GLU B 120
VAL B  68
 None
 1.44A 4odoC-3ol2B:
0.5		 4odoC-3ol2B:
15.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R29_D_SAMD301_1
(UNCHARACTERIZED
PROTEIN)		 3ol2 PLEXIN-B1
(Homo
sapiens) 		3 / 3 ARG B  40
GLU B 464
TYR B 467
 None
 0.84A 4r29D-3ol2B:
undetectable		 4r29D-3ol2B:
15.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A7M_A_ACTA1923_0
(BETA-XYLOSIDASE)		 3ol2 PLEXIN-B1
(Homo
sapiens) 		3 / 3 ASP B 496
ARG B 430
TYR B 498
 None
 0.86A 5a7mA-3ol2B:
undetectable		 5a7mA-3ol2B:
22.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A7M_B_ACTB1924_0
(BETA-XYLOSIDASE)		 3ol2 PLEXIN-B1
(Homo
sapiens) 		3 / 3 ASP B 496
ARG B 430
TYR B 498
 None
 0.90A 5a7mB-3ol2B:
undetectable		 5a7mB-3ol2B:
22.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CDQ_E_MFXE2101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT
B,DNA GYRASE SUBUNIT
B)		 3ol2 PLEXIN-B1
(Homo
sapiens) 		4 / 5 SER B 241
ARG B 272
GLY B 270
GLU B 269
 None
 1.18A 5cdqA-3ol2B:
undetectable
5cdqB-3ol2B:
undetectable
5cdqC-3ol2B:
undetectable		 5cdqA-3ol2B:
20.04
5cdqB-3ol2B:
16.57
5cdqC-3ol2B:
20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FSA_B_X2NB590_2
(CYP51 VARIANT1)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		3 / 3 PRO A 406
LEU A 293
SER A 282
 None
 0.76A 5fsaB-3ol2A:
undetectable		 5fsaB-3ol2A:
22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HV1_A_RFPA902_1
(PHOSPHOENOLPYRUVATE
SYNTHASE)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		5 / 12 GLN A 465
PRO A 499
ALA A 498
VAL A 496
ILE A  30
 None
 1.20A 5hv1A-3ol2A:
undetectable		 5hv1A-3ol2A:
21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IMS_A_ACTA708_0
(ACETOLACTATE
SYNTHASE CATALYTIC
SUBUNIT,
MITOCHONDRIAL)		 3ol2 SEMAPHORIN-4D
PLEXIN-B1
(Homo
sapiens;
Homo
sapiens) 		3 / 3 GLY B 180
GLY B 179
GLN A 392
 None
 0.49A 5imsA-3ol2B:
undetectable		 5imsA-3ol2B:
22.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IQB_A_KANA600_1
(BIFUNCTIONAL AAC/APH)		 3ol2 PLEXIN-B1
SEMAPHORIN-4D
(Homo
sapiens) 		5 / 12 SER B 199
ASP B 139
TYR B 200
GLU B 201
GLU A 200
 None
 1.13A 5iqbA-3ol2B:
0.7		 5iqbA-3ol2B:
17.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IQB_B_KANB600_1
(BIFUNCTIONAL AAC/APH)		 3ol2 PLEXIN-B1
SEMAPHORIN-4D
(Homo
sapiens) 		5 / 11 SER B 199
ASP B 139
TYR B 200
GLU B 201
GLU A 200
 None
 1.17A 5iqbB-3ol2B:
0.8		 5iqbB-3ol2B:
17.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IQC_B_51GB600_1
(BIFUNCTIONAL AAC/APH)		 3ol2 PLEXIN-B1
SEMAPHORIN-4D
(Homo
sapiens) 		5 / 10 SER B 199
ASP B 139
TYR B 200
GLU B 201
GLU A 200
 None
 1.10A 5iqcB-3ol2B:
0.0		 5iqcB-3ol2B:
17.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KVA_B_SAMB301_1
(CAFFEOYL-COA
O-METHYLTRANSFERASE)		 3ol2 PLEXIN-B1
(Homo
sapiens) 		3 / 3 THR B 140
SER B 199
ASP B 193
 None
 0.83A 5kvaB-3ol2B:
undetectable		 5kvaB-3ol2B:
18.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M66_A_ADNA502_2
(ADENOSYLHOMOCYSTEINA
SE)		 3ol2 PLEXIN-B1
(Homo
sapiens) 		4 / 4 GLN B 141
THR B 140
GLU B 201
LEU B 165
 None
 1.32A 5m66A-3ol2B:
undetectable		 5m66A-3ol2B:
23.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ND7_B_TA1B601_2
(TUBULIN BETA-2B
CHAIN)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		3 / 3 THR A 266
PRO A 365
ARG A 366
 None
 0.86A 5nd7B-3ol2A:
undetectable		 5nd7B-3ol2A:
20.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5T7B_A_IPHA901_0
(PROTEIN ARGONAUTE-2)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		4 / 6 PHE A 486
ALA A 498
PHE A 502
THR A 464
 None
 1.16A 5t7bA-3ol2A:
undetectable		 5t7bA-3ol2A:
22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UUN_A_ACTA309_0
(GLUTATHIONE
S-TRANSFERASE-LIKE
PROTEIN)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		4 / 4 LEU A 264
GLY A 263
SER A 383
SER A 382
 None
 0.97A 5uunA-3ol2A:
undetectable		 5uunA-3ol2A:
19.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UUN_B_ACTB306_0
(GLUTATHIONE
S-TRANSFERASE-LIKE
PROTEIN)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		4 / 4 LEU A 264
GLY A 263
SER A 383
SER A 382
 None
 0.94A 5uunB-3ol2A:
undetectable		 5uunB-3ol2A:
19.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B0C_D_TA1D502_1
(TUBULIN BETA CHAIN)		 3ol2 PLEXIN-B1
(Homo
sapiens) 		5 / 12 LEU B 466
LEU B 428
SER B 451
LEU B 457
THR B 458
 None
 0.84A 6b0cD-3ol2B:
undetectable		 6b0cD-3ol2B:
8.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DLZ_B_CYZB1302_0
(GLUTAMATE RECEPTOR
2,VOLTAGE-DEPENDENT
CALCIUM CHANNEL
GAMMA-2 SUBUNIT)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		5 / 10 LEU A 413
LEU A 312
ASP A 295
ILE A 460
SER A 442
 None
 1.36A 6dlzB-3ol2A:
undetectable
6dlzC-3ol2A:
undetectable		 6dlzB-3ol2A:
8.63
6dlzC-3ol2A:
8.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DLZ_D_CYZD1302_0
(GLUTAMATE RECEPTOR
2,VOLTAGE-DEPENDENT
CALCIUM CHANNEL
GAMMA-2 SUBUNIT)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		5 / 11 ILE A 460
SER A 442
LEU A 413
LEU A 312
ASP A 295
 None
 1.36A 6dlzA-3ol2A:
undetectable
6dlzD-3ol2A:
undetectable		 6dlzA-3ol2A:
8.63
6dlzD-3ol2A:
8.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DM1_B_CYZB1302_0
(GLUTAMATE RECEPTOR
2,VOLTAGE-DEPENDENT
CALCIUM CHANNEL
GAMMA-2 SUBUNIT)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		5 / 10 LEU A 413
LEU A 312
ASP A 295
ILE A 460
SER A 442
 None
 1.36A 6dm1B-3ol2A:
undetectable
6dm1C-3ol2A:
undetectable		 6dm1B-3ol2A:
8.63
6dm1C-3ol2A:
8.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DM1_D_CYZD1302_0
(GLUTAMATE RECEPTOR
2,VOLTAGE-DEPENDENT
CALCIUM CHANNEL
GAMMA-2 SUBUNIT)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		5 / 11 ILE A 460
SER A 442
LEU A 413
LEU A 312
ASP A 295
 None
 1.35A 6dm1A-3ol2A:
undetectable
6dm1D-3ol2A:
undetectable		 6dm1A-3ol2A:
8.63
6dm1D-3ol2A:
8.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DM2_B_CYZB1302_0
(GLUTAMATE RECEPTOR
2,VOLTAGE-DEPENDENT
CALCIUM CHANNEL
GAMMA-2 SUBUNIT)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		5 / 10 LEU A 413
LEU A 312
ASP A 295
ILE A 460
SER A 442
 None
 1.33A 6dm2B-3ol2A:
undetectable
6dm2C-3ol2A:
undetectable		 6dm2B-3ol2A:
8.63
6dm2C-3ol2A:
8.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DM2_D_CYZD1302_0
(GLUTAMATE RECEPTOR
2,VOLTAGE-DEPENDENT
CALCIUM CHANNEL
GAMMA-2 SUBUNIT)		 3ol2 SEMAPHORIN-4D
(Homo
sapiens) 		5 / 10 ILE A 460
SER A 442
LEU A 413
LEU A 312
ASP A 295
 None
 1.33A 6dm2A-3ol2A:
undetectable
6dm2D-3ol2A:
undetectable		 6dm2A-3ol2A:
8.63
6dm2D-3ol2A:
8.63